Glenmark Pharmaceuticals

    OverviewSuggest Edit

    We at Glenmark relentlessly strive to make the lives of patients better globally.

    With offices in over 40 countries, 17 manufacturing facilities across 5 countries and 5 R&D centers around the world, our dedication to enriching lives worldwide knows no bounds.

    Our vision has led us to discover new molecules that can make a difference to patients globally. As we look to the future, we are focused on developing high-quality generics and specialty products for markets across the globe.

    One of the real factors behind our success is our team of more than 12,000 employees from over 60 nationalities, who come together to make a new way for a new world.

    ... Show more
    TypePublic
    Founded1977
    HQMumbai, IN
    Websiteglenmarkpharma.com
    Employee Ratings3.3

    Latest Updates

    Employees (est.) (Jan 2017)7,000
    Job Openings32

    Key People/Management at Glenmark Pharmaceuticals

    Rajesh V Desai

    Rajesh V Desai

    Non-Executive Director
    Brian W Tempest

    Brian W Tempest

    Non-Executive Director
    Bernard Munos

    Bernard Munos

    Non-Executive Director
    Blanche E. Saldanha

    Blanche E. Saldanha

    Non-Executive Director
    Julio Ribeiro

    Julio Ribeiro

    Non-Executive Director
    Sridhar Gorthi

    Sridhar Gorthi

    Non-Executive Director
    Show more

    Glenmark Pharmaceuticals Office Locations

    Glenmark Pharmaceuticals has an office in Mumbai
    Mumbai, IN (HQ)
    Western Express Hwy
    Show all (1)
    Report incorrect company information

    Glenmark Pharmaceuticals News and Updates

    Glenmark Pharmaceuticals Ltd rises around 1%

    Glenmark Pharmaceuticals Ltd is quoting at Rs 585.1, up 1.03% on the day as on 12:54 IST on the NSE. The stock is up 11.46% in last one year as compared to a 2.67% gain in NIFTY and a 2.85% gain in the Nifty Pharma index.

    Glenmark Pharmaceuticals receives USFDA approval for Clobetasol Propionate Foam

    According to IQVIA sales data for the 12 month period ending December 2018, the Olux Foam, 0.05% market2 achieved annual sales of approximately $50.9 million

    Glenmark Pharmaceuticals Ltd Falls 4.27%, S&P BSE Healthcare index Drops 1.48%

    Glenmark Pharmaceuticals Ltd has lost 11.24% over last one month compared to 4.72% fall in S&P BSE Healthcare index and 1.39% drop in the SENSEX

    Glenmark Pharmaceuticals receives USFDA final approval for Sevelamer Hydrochloride Tablets

    According to IQVIATM sales data for the 12 month period ending December 2018, the Renagel Tablets, 400 mg and 800 mg market2 achieved annual sales of approximately $102.1 million.

    Glenmark Pharmaceuticals receives tentative ANDA approval for Fulvestrant Injection

    According to IQVIATM sales data for the 12 month period ending December 2018, the FASLODEX Injection, 250 mg/5 mL (50 mg/mL) market2 achieved annual sales of approximately $533.3 million.
    Show more
    Report incorrect company information

    Glenmark Pharmaceuticals Company Life and Culture

    Report incorrect company information

    Glenmark Pharmaceuticals Frequently Asked Questions

    • When was Glenmark Pharmaceuticals founded?

      Glenmark Pharmaceuticals was founded in 1977.

    • Who are Glenmark Pharmaceuticals key executives?

      Glenmark Pharmaceuticals's key executives are Rajesh V Desai, Brian W Tempest and Bernard Munos.

    • How many employees does Glenmark Pharmaceuticals have?

      Glenmark Pharmaceuticals has 7,000 employees.

    • Who are Glenmark Pharmaceuticals competitors?

      Competitors of Glenmark Pharmaceuticals include Clementia Pharmaceuticals, ProtoKinetix and Cryo-Cell International.

    • Where is Glenmark Pharmaceuticals headquarters?

      Glenmark Pharmaceuticals headquarters is located at Western Express Hwy, Mumbai.

    • Where are Glenmark Pharmaceuticals offices?

      Glenmark Pharmaceuticals has an office in Mumbai.

    • How many offices does Glenmark Pharmaceuticals have?

      Glenmark Pharmaceuticals has 1 office.